GSK Tries To Axe Wellbutrin Consumer Antitrust Suit

GlaxoSmithKline PLC has asked a judge to dismiss claims brought by employee benefit plans over the alleged filing of baseless patent suits to delay generic competition with Wellbutrin SR, arguing that...

Already a subscriber? Click here to view full article